Office of the Commissioner of Lobbying of Canada
Registry of Lobbyists

Monthly Communication Report

5088-676971

Corporation: GlaxoSmithKline Inc.
Associated registration: 953603-5088-87
Communication date: 2026-04-10
Posted date: 2026-04-13

Designated Public Office Holders who participated in the communication: Rodrigo Arancibia, Director
Life Science Industries Directorate, Innovation, Science and Economic Development Canada (ISED)
 
List of Details
Subject matter Detail
Budget, Economic Development, Government Procurement, Health Antimicrobial Resistance (AMR) - Seek funding and support for pilot projects making anti-infective medications available to equity seeking populations, helping to combat AMR. Also discuss any applicable conditions regarding this funding.
 
Responsible Officer who filed this communication report: Sridhar Venkatesh
 
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication.

The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.
 

Date Modified: